Please login to the form below

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Newly-listed BioNTech buys Neon to boost cell therapy assets

who are not responding to treatment with checkpoint inhibitor drugs like Bristol-Myers Squibb’s Opdivo (nivolumab) and Merck &Co’s Keytruda (pembrolizumab).

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

A combination trial of Rubraca plus Bristol-Myers Squibb’s checkpoint inhibitor Opdivo (nivolumab) – called CheckMate 9KD – is also ongoing with initial results due later this year.

FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC

A verdict is expected to be delivered by 15 May. Bristol-Myers Squibb’s marathon to get approval for its immuno-oncology drug Opdivo in first-line non-small cell lung

Nektar’s opioid analgesic slammed with FDA panel rejection

The Bristol-Myers Squibb-partnered CD122-biased agonist NKTR-214 is due to start two new phase 3 studies soon, with the partners working on investigating the drug in 20 indications

BMS expands collaboration with Nektar, sending shares soaring

Adds research programmes in an additional two cancer types. Bristol-Myers Squibb has expanded its development programme with Nektar, sending shares in the biotech soaring by nearly 20%. . ... Bristol-Myers Squibb and Nektar view bempeg as an important

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Account Director or Senior Account Director: Salary TBC

Account Manager– Medical Communications: (Negotiable - depending on experience)

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Vice President: Competitive Salary Offered

Consultant: competitive salary

Senior Medical Writer, MedComms Agency: Salary TBC

How do companies prepare for reimbursement?: Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
Integrating electronic health records into clinical trials: How organisations are working to realise the research potential of EHRs...
Keeping up the fight against HIV and using the lessons to tackle other threats: Danny Buckland interviews Gilead’s Mike Elliott...